Yao et al. confirmed that the miR-34a-5p/Axl axis plays an aggressive role in oral cancer cells through the Akt/GSK-3 and β/β-catenin/Snail signal transduction pathways and may be a therapeutic target for oral squamous cell carcinoma [57]. Here, AXL is linked to lip and oral cavity carcinoma.